Delivery Order SPE2DB20D7059-SPE2DB24FQCL0
Award Date 3/26/24
Potential Completion Date 3/27/24
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $17,748.27 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the supply of ADALIMUMAB 2PPN 2S, a pharmaceutical product, with a period of performance through July 31, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $16,331.41 to AmerisourceBergen Drug Corp for Adalimumab 2PPN 2S, a pharmaceutical product, with performance at the contractor's Conshohocken, Pennsylvania facility. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 29, 2025, and represents a child contract under a larger indefinite delivery vehicle. The contract contains no set-aside designation, reflecting the contractor's proven...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,847.20 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,465.39 contract is for the supply of ADALIMUMAB-ADAZ(CF) PEN 40 MG 0.4ML, a specialty medication. The award is not designated as a set-aside contract. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $12,305.83 to AmerisourceBergen Drug Corp for Adalimumab 2PPN 2S on December 10, 2025, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,956.41 to AmerisourceBergen Drug Corp, a subsidiary of the for-profit parent company AmerisourceBergen Corporation. The contract is for the supply of HUMIRA (CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,440.98 Firm Fixed Price Delivery Order contract is for the supply of ADALIMUMAB-ADBM(CF) 40 MG SYRGS, a pharmaceutical product, with a period of performance through March 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a $2,324.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) CF pen 40 mg/0.4 mL on November 14, 2025, with completion targeted for November 17, 2025. This is an unset-aside, competitively awarded contract with place of performance in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,979.90 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) pen 40 mg/0.4 mL units, with an ultimate completion date of December 1, 2025. This non-competitive delivery order represents a firm fixed-price transaction under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be performed at the vendor's facility in Conshohocken, Pennsylvania, where...
- The federal contract award is for the delivery of ADALIMUMAB 2PPN 2S medical supplies to the U.S. government. The contract, valued at $3,776.50, is a Firm Fixed Price Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is non-set-aside, indicating open competition. The contract is funded by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support. The contract is part of...